Overview
- 120 inspections across 113 sites are on record.
- 499 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-11-22.
At a glance
Inspections
120
Sites
113
Observations
499
Career since
Mar 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | 22 Nov 2024 | Human Drugs | View 483 → |
| BROOKS STERISCIENCE LIMITED | 12 Nov 2024 | Human Drugs | View 483 → |
| Global Calcium Pvt. Limited | 2 Aug 2024 | Human Drugs | On file |
| Biocon Biologics Limited | 26 Jul 2024 | Human Drugs | On file |
| Aurore Pharmaceuticals Private Limited | 31 May 2024 | Human Drugs | On file |
Sites inspected
Alembic Pharmaceuticals LimitedVadodara, India1 insp.
BROOKS STERISCIENCE LIMITEDVadodara, India1 insp.
Global Calcium Pvt. LimitedHosur, India1 insp.
Biocon Biologics LimitedBengaluru, India1 insp.
Aurore Pharmaceuticals Private LimitedHyderabad, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Emir Galevi9 shared
Rachel Peters7 shared
Justin A Boyd4 shared
Gabriel E Muniz4 shared
Clara E Santiago4 shared
Miguel A Martinez3 shared
Jennifer Lalama3 shared
Earl Echon3 shared
Arsen Karapetyan2 shared
Jonah S Ufferfilge2 shared
Full investigator report
Get the verbatim findings behind Teresa I Navas' 499 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site